Nelson Vergel Beyond Testosterone Podcast

Retatrutide is generating major interest as an experimental triple agonist for weight loss, but what does the science show, and where do the risks begin? In this podcast, we break down the latest clinical trial data, separate research findings from unregulated community use, and explain what men and women should know about hormonal changes, fertility, side effects, and muscle loss. We also cover practical strategies for protecting lean mass through higher protein intake and resistance training. If you are curious about retatrutide, considering future treatment options, or trying to understand the growing discussion around this emerging obesity therapy, this episode gives you the evidence, context, and safety considerations you need. Read more here: Retatrutide for Beginners: GLP-3 Starting Guide & Titration

Explore the controversial world of peptide biohacking where thousands of men bypass traditional medical systems to self-administer gray-market compounds aimed at reversing aging, healing injuries, and altering body composition.
This episode follows Nelson Vergel and the Excel Mail community as they navigate evidence tiers, risks like endotoxin contamination and cancer concerns, and the shifting 2026 regulatory landscape — from secretagogues and tissue-repair peptides to GLP-1 weight-loss drugs and experimental mitochondrial therapies.

The gym has lied to you for decades. The American College of Sports Medicine just dropped their first major resistance training update in 17 years — and the findings completely overturn what most people think they know about building muscle. Based on 137 systematic reviews and over 30,000 participants, the new science is simpler, more accessible, and more empowering than anything you've seen on social media.
🧠 WHAT YOU'LL LEARN:- Why the 8–12 rep rule is officially a myth (and what actually builds muscle)- How lighter weights can be just as effective for hypertrophy as heavy ones- Why you don't need a gym, a barbell, or even a workout plan to get results- The silent muscle loss that begins at age 30 — and how to stop it- The exact 20-minute routine the new guidelines say is enough to transform your health
⚠️ DISCLAIMER: This content is for educational purposes only and is based on published scientific research. It does not constitute medical advice. Consult a qualified healthcare provider before beginning any exercise program, especially if you have a pre-existing medical condition or injury.

This podcast episode discuss ibogaine, a psychoactive alkaloid derived from African plants that shows significant potential for treating addiction, PTSD, and traumatic brain injuries. Unlike traditional maintenance drugs, ibogaine acts as a "neurological reboot" by interrupting withdrawal symptoms and fostering deep psychological introspection. Recent clinical research, specifically the Stanford MISTIC protocol, demonstrates that co-administering magnesium can mitigate the substance's primary risk of cardiac toxicity. Advanced neuroimaging indicates that the treatment facilitates a "posterior shift" in brain waves, allowing the mind to release rigid trauma loops and repair damaged neural circuits. While it remains a Schedule I substance in the United States, recent federal executive orders and state-funded initiatives in Texas are accelerating the development of pharmaceutical analogs. These synthetic versions aim to preserve the medicine’s restorative benefits while eliminating its long hallucinogenic duration and heart risks. #ibogaine #psychedelic

By early 2026, the psychedelic medicine sector has entered a critical period of clinical and regulatory maturation marked by both significant breakthroughs and institutional challenges. While the FDA’s rejection of MDMA-assisted therapy necessitated stricter trial designs across the industry, Compass Pathways achieved a historic milestone with the first successful Phase 3 psilocybin results. Major pharmaceutical players have signaled confidence in the field, highlighted by AbbVie's billion-dollar acquisition of a novel tryptamine program. Multiple substances, including LSD, DMT, and ketamine derivatives, are currently advancing through late-stage testing for conditions like depression, anxiety, and PTSD. Consequently, a potential shift toward streamlined FDA approval policies may soon allow these once-stigmatized compounds to enter the mainstream medical market. Currently, the landscape is defined by a diverse pipeline of breakthrough-designated therapies nearing final regulatory decisions.

The episode captures a discussion on nitric oxide (NO) biology and highlights the molecule's profound importance in metabolic health and chronic disease reversal. It explains that a deficiency in this "miracle molecule" leads to a recognizable hierarchy of symptoms, often beginning with erectile dysfunction and progressing to severe conditions like hypertension and insulin resistance. Experts in the field criticize the supplement industry, arguing that products using arginine or beet juice are largely ineffective because they fail to restore the body’s natural NO production pathway, which is damaged by common factors like high sugar intake and the use of acid blockers (PPIs). Instead of symptom management, many expert advocate for a restorative physiological approach, using science-backed technology to replace lost NO and pursuing FDA-approved NO drug therapies for illnesses such as Alzheimer’s and non-healing diabetic wounds. This work aims to shift the narrative from ineffective drug cocktails to addressing the root cause of endothelial dysfunction.

In this comprehensive episode, you will learn: 1. A Deep Dive into the Science: Uncover exactly how the Androgen Receptor gene works and why this single genetic marker has such a massive and wide-ranging impact on a man's life. 2. Are You High or Low?: Explore the average CAG repeat numbers for different global populations—including European (21), African (17), and Asian (23)—and understand what the "normal" range is. 3. Testing Options Explained: Learn about the types of genetic tests available, their cost, and how you can have an informed discussion with your doctor about getting tested. 4. Actionable Steps: Discover how to interpret your potential results and what they mean for optimizing your health, energy, and vitality—whether you are currently on TRT or not.

The FDA has just dropped a bombshell that could affect nearly 2 million Americans taking natural thyroid medication. In a controversial move, they've reclassified desiccated thyroid extract, or DTE, as a biologic rather than a traditional drug. This means compounding pharmacies have exactly one year before they must stop making the customized thyroid medications that countless patients depend on. Critics are calling foul, arguing the decision is based on an inactive pig protein that gets digested in your stomach anyway, and pointing out that the real active ingredients - T4 and T3 hormones - haven't changed. What's really raising eyebrows is that this shift appears linked to a petition from AbbVie, the company behind brand-name Armour Thyroid, potentially setting up a monopoly situation.